Biscayne Pharmaceuticals, Inc.

In a summer slowdown, biopharmaceutical start-up fundraising declined 27% in the third quarter of 2018, but Gossamer Bio Inc. and Orchard Therapeutics Ltd. brought in large venture capital rounds

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar

Biopharmaceutical start-ups brought in 19% less funding in the first quarter of 2017 as compared with the previous quarter, but venture capital investors placed big bets on a few new companies, includ

The two epilepsy NDAs pending at FDA illustrate the two poles of research into new molecular entities for the seizure disorder: incremental improvements over proven drugs and novel mechanisms of actio